01 2ADALIMUMAB-ATTO
02 1AFLIBERCEPT-AYYH
03 7APREMILAST
04 1AVACOPAN
05 2BEVACIZUMAB-AWWB
06 1BLINATUMOMAB
07 3CARFILZOMIB
08 3CINACALCET HYDROCHLORIDE
09 4CYSTEAMINE BITARTRATE
10 10DARBEPOETIN ALFA
11 2DENOSUMAB
12 1DICLOFENAC SODIUM
13 1ECULIZUMAB-AEEB
14 7EPOETIN ALFA
15 1ERENUMAB-AOOE
16 2ESOMEPRAZOLE MAGNESIUM; NAPROXEN
17 2ETANERCEPT
18 3ETELCALCETIDE
19 1EVOLOCUMAB
20 1FAMOTIDINE; IBUPROFEN
21 4FILGRASTIM
22 1GLYCEROL PHENYLBUTYRATE
23 1INFLIXIMAB-AXXQ
24 1INTERFERON GAMMA-1B
25 1IVABRADINE
26 2IVABRADINE HYDROCHLORIDE
27 1LEVOMEPROMAZINE
28 1OXALIPLATIN
29 2PAMIDRONATE DISODIUM
30 3PANITUMUMAB
31 1PEGFILGRASTIM
32 1PEGLOTICASE
33 3PREDNISONE
34 1RITUXIMAB-ARRX
35 1ROMIPLOSTIM
36 1ROMOSOZUMAB-AQQG
37 2SODIUM PHENYLBUTYRATE
38 3SOTORASIB
39 2TARLATAMAB-DLLE
40 1TEPROTUMUMAB-TRBW
41 2THIOTEPA
42 2TRASTUZUMAB-ANNS
43 3USTEKINUMAB-AUUB
01 2CAPSULE, DELAYED RELEASE;ORAL
02 1CAPSULE;ORAL
03 2GRANULE, DELAYED RELEASE;ORAL
04 4INJECTABLE; INJECTION
05 3INJECTABLE; IV (INFUSION)
06 3INJECTABLE; SUBCUTANEOUS
07 18INJECTABLE;INJECTION
08 3INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
09 1LIQUID;ORAL
10 3POWDER;INTRAVENOUS
11 1POWDER;ORAL
12 3SOLUTION;INTRAVENOUS
13 1SOLUTION;ORAL
14 1SOLUTION;TOPICAL
15 4SYRINGE
16 5TABLET, DELAYED RELEASE;ORAL
17 1TABLET, EXTENDED RELEASE;ORAL
18 16TABLET;ORAL
19 2VIAL
20 5VIAL; INTRAVENOUS
21 3VIAL; MULTIDOSE
22 6VIAL; SINGLE-USE
23 6VIAL; SUBCUTANEOUS
24 1VIAL;SINGLE-DOSE
01 11.1GM/ML
02 110,000U/ML
03 1100MG/10ML(10MG/ML)
04 1100MG/4ML (25MG/ML)
05 1100MG/VIAL
06 1100UG/0.5ML
07 2100UG/ML
08 1105MG/1.17ML
09 410MG
10 110MG/2ML (5MG/ML)
11 110MG/VIAL
12 110ML/200MG
13 1120MG
14 1130MG/26ML
15 1140MG/ML
16 1150MG
17 115MG/VIAL
18 115MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
19 21MG
20 12 mg (0.05 mL of 40 mg/mL)
21 12% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
22 12,000U/ML
23 12.5MG/0.5ML (2.5MG/0.5ML)
24 120,000/ML
25 120,000U/2ML
26 2200UG/ML
27 220MG
28 120MG/0.4ML
29 120MG/ML
30 120ML/400MG
31 1240MG
32 1250MCG/0.5ML; 500MCG/1ML.
33 125MG/VIAL
34 225UG/ML
35 126.6MG;800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
36 12MG
37 13,000U/ML
38 1300MCG/1ML
39 1300MG/30ML(10MG/ML)
40 1300MGC/0.5ML
41 230MG
42 230MG/VIAL
43 1320MG
44 135MCG
45 13GM/TEASPOONFUL
46 14,000U/ML
47 140,000U/ML
48 1400MG/16ML (25MG/ML)
49 140MG/0.8ML
50 240UG/ML
51 1420MG
52 145MG/0.5ML
53 1480MCG/0.8ML
54 1480MCG/1.6ML
55 2500MG
56 150MG/ML
57 15MG
58 15MG/5ML (1MG/ML)
59 15MG/ML
60 15MG/ML (5MG/ML)
61 15ML/100MG
62 160MG/ML
63 160MG/VIAL
64 260UG/ML
65 16MG/0.6ML
66 270MG/ML
67 175MG
68 18MG
69 190MG/ML
70 190MG/VIAL
71 1EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
72 1EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
73 1EQ 25MG BASE
74 1EQ 300MG BASE/PACKET
75 1EQ 30MG BASE
76 1EQ 5MG BASE
77 1EQ 60MG BASE
78 1EQ 7.5MG BASE
79 1EQ 75MG BASE
80 1EQ 75MG BASE/PACKET
81 1EQ 90MG BASE
01 20DISCN
02 19RX
03 56Blank
RLD :
TE Code :
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : AMJEVITA
Dosage Strength : 20MG/0.4ML
Approval Date :
Application Number : 761024
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : AMJEVITA
Dosage Strength : 40MG/0.8ML
Approval Date :
Application Number : 761024
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : PAVBLU
Dosage Strength : 2 mg (0.05 mL of 40 mg/m...
Approval Date :
Application Number : 761298
RX/OTC/DISCN :
RLD :
TE Code :
RLD : Yes
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : OTEZLA
Dosage Strength : 10MG
Approval Date : 2014-03-21
Application Number : 205437
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : OTEZLA
Dosage Strength : 20MG
Approval Date : 2014-03-21
Application Number : 205437
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : OTEZLA
Dosage Strength : 30MG
Approval Date : 2014-03-21
Application Number : 205437
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code :
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Proprietary Name : OTEZLA XR
Dosage Strength : 75MG
Approval Date : 2025-08-29
Application Number : 210745
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD :
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : OTEZLA
Dosage Strength : 10MG
Approval Date :
Application Number : 210745
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : OTEZLA
Dosage Strength : 20MG
Approval Date :
Application Number : 210745
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : OTEZLA
Dosage Strength : 30MG
Approval Date :
Application Number : 210745
RX/OTC/DISCN :
RLD :
TE Code :
Amgen Inc is a supplier offers 11 products (APIs, Excipients or Intermediates).
Find AMG 282 DRUG SUBSTANCE bulk with DMF offered by Amgen Inc
Find AMG 191 DRUG SUBSTANCE bulk with DMF offered by Amgen Inc
Find AMG 157 (TEZEPELUMAB) PHASE 3 CMC AMENDMENT (DRUG SUBSTANCE AND DRUG PRODUCT) bulk with DMF offered by Amgen Inc
Find AMG 191 DRUG PRODUCT bulk with DMF offered by Amgen Inc
Find INTRAVENOUS SOLUTION STABILIZER (IVSS) bulk with DMF offered by Amgen Inc
Find AMG 191 CELL LINE DEVELOPMENT bulk with DMF offered by Amgen Inc
Find HUMAN MONOCLONAL ANTIBODY (ABX-EGF) TO EPIDERMAL GROWTH FACTOR RECEPTOR bulk offered by Amgen Inc
Find HUMAN MONOCLONAL ANTIBODY (MDX-015)(SP2/0,- AG14 CELLS, MEDAREX) TO IL15 bulk offered by Amgen Inc
Find BULK PURIFIED MURINE MONOCLONAL ANTIBODY (ABX-CBL) TO BLAST CELLS bulk offered by Amgen Inc
Find Carfilzomib bulk offered by Amgen Inc
Find Recombinant Human Growth Hormone bulk offered by Amgen Inc
